RU2314809C2 - Способ лечения депрессии соединениями-агонистами дельта-рецепторов - Google Patents
Способ лечения депрессии соединениями-агонистами дельта-рецепторов Download PDFInfo
- Publication number
- RU2314809C2 RU2314809C2 RU2004115748/14A RU2004115748A RU2314809C2 RU 2314809 C2 RU2314809 C2 RU 2314809C2 RU 2004115748/14 A RU2004115748/14 A RU 2004115748/14A RU 2004115748 A RU2004115748 A RU 2004115748A RU 2314809 C2 RU2314809 C2 RU 2314809C2
- Authority
- RU
- Russia
- Prior art keywords
- composition
- group
- combating
- depressive disorder
- disorder
- Prior art date
Links
- 208000020401 Depressive disease Diseases 0.000 title claims abstract 14
- 238000000034 method Methods 0.000 title claims abstract 11
- 101100244562 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) oprD gene Proteins 0.000 title abstract 3
- 239000000556 agonist Substances 0.000 title abstract 3
- 108700023159 delta Opioid Receptors Proteins 0.000 title abstract 3
- 102000048124 delta Opioid Receptors Human genes 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 claims abstract 15
- 150000001875 compounds Chemical class 0.000 claims abstract 9
- 150000002148 esters Chemical class 0.000 claims abstract 7
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims abstract 6
- 125000003118 aryl group Chemical group 0.000 claims abstract 6
- 229910052799 carbon Inorganic materials 0.000 claims abstract 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 5
- 150000003839 salts Chemical class 0.000 claims abstract 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 3
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 claims abstract 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract 3
- 230000001430 anti-depressive effect Effects 0.000 claims abstract 2
- 239000003795 chemical substances by application Substances 0.000 claims 12
- 229940123445 Tricyclic antidepressant Drugs 0.000 claims 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 4
- 239000000013 adrenergic uptake inhibitor Substances 0.000 claims 4
- 229940082992 antihypertensives mao inhibitors Drugs 0.000 claims 4
- 239000003420 antiserotonin agent Substances 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 239000002899 monoamine oxidase inhibitor Substances 0.000 claims 4
- 239000000952 serotonin receptor agonist Substances 0.000 claims 4
- 239000003772 serotonin uptake inhibitor Substances 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 239000003029 tricyclic antidepressant agent Substances 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000006186 oral dosage form Substances 0.000 claims 2
- 208000019022 Mood disease Diseases 0.000 claims 1
- 239000000841 delta opiate receptor agonist Substances 0.000 claims 1
- 230000003001 depressive effect Effects 0.000 claims 1
- 238000001361 intraarterial administration Methods 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007913 intrathecal administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 230000001926 lymphatic effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34008401P | 2001-10-29 | 2001-10-29 | |
| US60/340,084 | 2001-10-29 | ||
| US33788701P | 2001-11-02 | 2001-11-02 | |
| US60/337,887 | 2001-11-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2004115748A RU2004115748A (ru) | 2005-03-27 |
| RU2314809C2 true RU2314809C2 (ru) | 2008-01-20 |
Family
ID=26990913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004115748/14A RU2314809C2 (ru) | 2001-10-29 | 2002-10-29 | Способ лечения депрессии соединениями-агонистами дельта-рецепторов |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7030124B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1450807B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4892654B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1596113B (cg-RX-API-DMAC7.html) |
| CA (1) | CA2464471C (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04004059A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20042257L (cg-RX-API-DMAC7.html) |
| PL (1) | PL371297A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2314809C2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200300089A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003037342A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1269805C (zh) * | 2001-05-18 | 2006-08-16 | 阿斯特拉曾尼卡有限公司 | 4－(苯基－哌嗪基－甲基)－苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用 |
| US8476280B2 (en) * | 2002-05-09 | 2013-07-02 | Versi Group, Llc | Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| SE0203300D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203303D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| US7314880B2 (en) * | 2003-01-02 | 2008-01-01 | Mount Cook Biosciences, Inc. | Cardioprotective delta opioid receptor agonists and methods of using same |
| NZ593444A (en) | 2003-10-01 | 2012-12-21 | Adolor Corp | 4-[(2-N,N-diethylaminocarbonyl)pyrid-5-yl]-spiro[1,2-dihydronaphthalene-2,4'-piperidine] and methods of its use |
| MX2007001240A (es) * | 2004-08-02 | 2007-03-23 | Astrazeneca Ab | Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas. |
| SE0401968D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| US7683168B2 (en) * | 2005-04-14 | 2010-03-23 | Mount Cook Bio Sciences, Inc. | Compositions of novel opioid compounds and method of use thereof |
| TW200803856A (en) | 2005-09-02 | 2008-01-16 | Mount Cook Biosciences Inc | Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| NZ590041A (en) * | 2008-05-20 | 2012-11-30 | Astrazeneca Ab | Method of treating anxious major depressive disorder |
| CN103467460A (zh) * | 2013-09-23 | 2013-12-25 | 昆明理工大学 | 一类含噻吩环和苄基的二芳基甲基哌嗪化合物及其应用 |
| CN105646151B (zh) * | 2016-02-26 | 2018-06-29 | 山西大学 | 一种炔类化合物及其制备方法和该化合物的用途 |
| WO2017173067A1 (en) | 2016-03-31 | 2017-10-05 | Versi Group, Llc | Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinson's disease |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| RU2133744C1 (ru) * | 1993-07-30 | 1999-07-27 | Дельта Фармасьютикалз, Инк. | Пиперазиновые соединения |
| JP2000026385A (ja) * | 1998-04-16 | 2000-01-25 | Pfizer Prod Inc | Ｎ―アシル及びｎ―アロイルアラルキルアミド |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807858A (en) * | 1996-06-05 | 1998-09-15 | Delta Pharmaceutical, Inc. | Compositions and methods for reducing respiratory depression |
| US5681830A (en) * | 1992-02-03 | 1997-10-28 | Delta Pharmaceuticals, Inc. | Opioid compounds |
| US5574159A (en) * | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
| GB9202238D0 (en) * | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| US5985880A (en) * | 1996-06-05 | 1999-11-16 | Delta Pharmaceuticals | Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| US20020052007A1 (en) * | 1992-02-03 | 2002-05-02 | Chang Kwen Jen | Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
| US6046200A (en) * | 1994-09-09 | 2000-04-04 | The United States Of America As Represented By The Secretary Of The Army | Compositions having neuroprotective and analgesic activity |
| SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| GB9709972D0 (en) * | 1997-05-19 | 1997-07-09 | Pfizer Ltd | Tetrazoles |
| GB9804734D0 (en) * | 1998-03-05 | 1998-04-29 | Pfizer Ltd | Compounds |
| SE9904673D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904674D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904675D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| GB0017256D0 (en) * | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
| CN1269805C (zh) | 2001-05-18 | 2006-08-16 | 阿斯特拉曾尼卡有限公司 | 4－(苯基－哌嗪基－甲基)－苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用 |
-
2002
- 2002-10-29 CN CN028237099A patent/CN1596113B/zh not_active Expired - Fee Related
- 2002-10-29 WO PCT/US2002/034421 patent/WO2003037342A1/en not_active Ceased
- 2002-10-29 RU RU2004115748/14A patent/RU2314809C2/ru not_active IP Right Cessation
- 2002-10-29 PL PL02371297A patent/PL371297A1/xx unknown
- 2002-10-29 EP EP02789294.2A patent/EP1450807B1/en not_active Expired - Lifetime
- 2002-10-29 JP JP2003539685A patent/JP4892654B2/ja not_active Expired - Fee Related
- 2002-10-29 CA CA2464471A patent/CA2464471C/en not_active Expired - Fee Related
- 2002-10-29 US US10/282,411 patent/US7030124B2/en not_active Expired - Fee Related
- 2002-10-29 MX MXPA04004059A patent/MXPA04004059A/es unknown
- 2002-10-29 TW TW091132060A patent/TW200300089A/zh unknown
-
2004
- 2004-06-01 NO NO20042257A patent/NO20042257L/no not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| RU2133744C1 (ru) * | 1993-07-30 | 1999-07-27 | Дельта Фармасьютикалз, Инк. | Пиперазиновые соединения |
| JP2000026385A (ja) * | 1998-04-16 | 2000-01-25 | Pfizer Prod Inc | Ｎ―アシル及びｎ―アロイルアラルキルアミド |
Non-Patent Citations (1)
| Title |
|---|
| Каплан Г.И. и др. Клиническая психиатрия в 2 тт., пер. с англ. - М.: Медицина, 1994, т.1, с.63-64, 315-330, 339-342 - расстройства настроения. Plobeck N. et al. New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased in vitro metabolic stability // J. Med. Chem. 2000 Oct 19; 43(21): 3878-94. Fumess М. Scott et al. Probes for narcotic receptor-mediated phenomena/ Synthesis and pharmacological evaluation of selective δ-opioid receptor agonists from 4-[(αR)-α-(2S,5R)-4-substituted-2,5-dimethyl-1-piperazmyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers // Journal of Medicinal chemistry, 2000, 43(16):3193-3196. * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003037342A1 (en) | 2003-05-08 |
| CN1596113B (zh) | 2010-05-26 |
| TW200300089A (en) | 2003-05-16 |
| US7030124B2 (en) | 2006-04-18 |
| CA2464471C (en) | 2012-05-15 |
| MXPA04004059A (es) | 2005-03-31 |
| EP1450807B1 (en) | 2013-12-25 |
| CN1596113A (zh) | 2005-03-16 |
| US20030144299A1 (en) | 2003-07-31 |
| CA2464471A1 (en) | 2003-05-08 |
| EP1450807A4 (en) | 2008-06-25 |
| JP2005508363A (ja) | 2005-03-31 |
| EP1450807A1 (en) | 2004-09-01 |
| NO20042257L (no) | 2004-06-24 |
| RU2004115748A (ru) | 2005-03-27 |
| JP4892654B2 (ja) | 2012-03-07 |
| PL371297A1 (en) | 2005-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2314809C2 (ru) | Способ лечения депрессии соединениями-агонистами дельта-рецепторов | |
| RU2317294C2 (ru) | (имидазол-1-илметил)пиридазин в качестве блокатора nmda рецептора | |
| EP2283833A2 (en) | Amines and amides for the treatment of diseases | |
| IL182746A (en) | Use of conventional antidepressants and a number of carbohydrates in the preparation of antidepressants | |
| JPWO2018079693A1 (ja) | （ｓ）−ノルケタミンおよびその塩の医薬品としての応用 | |
| TWI224102B (en) | Serotonergic agents | |
| RU2009102278A (ru) | Модуляторы рецептора s1p для лечения рассеянного склероза | |
| JP2002538176A (ja) | トラマドール物質および選択的ｃｏｘ−２阻害薬を含んで成る組成物 | |
| KR20070083534A (ko) | 체중감량을 위한 부프로피온과 제2화합물의 조합 | |
| JP6518595B2 (ja) | １−インダンスルファミド誘導体を含む疼痛の治療および／または予防剤 | |
| BRPI0609952A2 (pt) | métodos para modular a função da bexiga | |
| EP1358177B1 (en) | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance | |
| BRPI0610509A2 (pt) | tratamento de dependência a drogas | |
| JP2005508363A5 (cg-RX-API-DMAC7.html) | ||
| CN1652758A (zh) | 使用文拉法辛和衍生物治疗胃肠和泌尿生殖疼痛症的方法 | |
| BRPI0612216A2 (pt) | uso de um composto, uso de um ligante do receptor h3 e combinação | |
| US6562858B2 (en) | Method for treating depression | |
| RU2010154417A (ru) | Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств | |
| KR20010024548A (ko) | 질병관련 또는 약물유발 운동장해의 치료방법 | |
| KR20080002906A (ko) | 비이미다졸 알킬아민 히스타민 ｈ3-수용기 리간드로 간질의치료 | |
| CN1859846A (zh) | 白屈菜赤碱、其类似物及其在治疗躁郁症和其他认知紊乱中的应用 | |
| RU2008101776A (ru) | Соединения для ингибирования обратного захвата 5-гидрокситриптамина и норэпинефрина или для лечения депрессивных состояний, способы их получения и применения | |
| EA003546B1 (ru) | Новые способы лечения нервных расстройств | |
| JPWO2023069880A5 (cg-RX-API-DMAC7.html) | ||
| EP1010425A9 (en) | Remedies for irritable bowel syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20101030 |